Qube Research & Technologies (QRT)
ATRA icon

Qube Research & Technologies (QRT)’s Atara Biotherapeutics ATRA Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio ATRA Stock Details ATRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-102,663
Closed -$873K – 3299
2024
Q2 		$873K Buy
+102,663
New +$1.54M ﹤0.01% 1956
2023
Q3 		– Sell
-1,396
Closed -$56.2K – 4081
2023
Q2 		$56.2K Buy
+1,396
New +$78.9K ﹤0.01% 2059
2023
Q1 		– Sell
-2,240
Closed -$184K – 2527
2022
Q4 		$184K Buy
+2,240
New +$233K ﹤0.01% 1849
2022
Q2 		– Sell
-947
Closed -$220K – 2478
2022
Q1 		$220K Buy
+947
New +$302K ﹤0.01% 1915
2021
Q3 		– Sell
-784
Closed -$305K – 2190
2021
Q2 		$305K Sell
784
-2,488
-76% -$887K ﹤0.01% 1571
2021
Q1 		$1.18M Buy
3,272
+1,463
+81% +$647K 0.02% 786
2020
Q4 		$888K Buy
+1,809
New +$835K 0.01% 912

Other funds holding ATRA

EC
EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return